Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors

被引:66
|
作者
Lin, Mong-Wei [1 ]
Chang, Yih-Leong [2 ]
Huang, Pei-Ming [1 ]
Lee, Yung-Chie [1 ]
机构
[1] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10002, Taiwan
[2] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10002, Taiwan
关键词
Myasthenia gravis; Thymectomy; Video-assisted thoracoscopic surgery; ASSISTED THORACOSCOPIC THYMECTOMY; TRANSSTERNAL THYMECTOMY; AUTOIMMUNE MYASTHENIA; EXTENDED THYMECTOMY; THORACIC-SURGERY; EXPERIENCE; STANDARDS;
D O I
10.1016/j.ejcts.2009.05.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: While thymectomy is an accepted treatment for myasthenia gravis (MG), video-assisted thoracoscopic surgery (VATS) thymectomy has recently become a popular surgical treatment, especially for non-thymomatous MG (NTMG). This study aims to compare the results of VATS thymectomy and trans-sternal thymectomy, and identify prognostic factors in NTMG patients after thymectomy. Methods: A 10-year retrospective review (January 1995 to December 2004) of 60 consecutive thymectomies (22 trans-sternal thymectomies and 38 VATS thymectomies) of NTMG patients performed in a university teaching hospital was undertaken. Results: There were 43 female patients and 17 male patients with a median MG-onset age of 25 years (range: 5-78 years). Median follow-up time was 44 months. VATS thymectomy patients had a shorter hospital stay than the trans-sternal thymectomy patients (5.6 days vs 8.1 days, p = 0.008). There was no other statistically significant difference between the two operative methods in NTMG patients, including intensive care unit (ICU) stay, ventilator support time, operative time, postoperative status, complete stable remission (CSR) rate, morbidity and mortality. Three prognostic factors associated with better remission rate were hyperthyroidism (p = 0.003), age <40 years (p = 0.022) and the presence of thymic hyperplasia (p = 0.041). Other factors, including gender, disease duration, preoperative MG severity, acetylcholine receptor antibody, perioperative therapy and operative methods (32% vs 36%, p = 0.91, 95% confidence interval (CI) = 0.27-3.21) were not statistically relevant to better remission rate. Conclusions: VATS thymectomy is more advantageous for NTMG patients because of shorter hospital stay, less tissue injury, better cosmetic result and equivalent CSR rate. NTMG patients aged <40 years with hyperthyroidism and a histologic diagnosis of lymphofollicular hyperplasia have better chances of remission after thymectomy. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [31] MULTISCIPLINARY APPROACH OF NON-THYMOMATOUS MYASTHENIA GRAVIS
    Migliore, Marcello
    Vecchio, Ignazio
    Rampello, Luigi
    Borrata, Francesco
    Astuto, Marinella
    Rampello, Liborio
    ACTA MEDICA MEDITERRANEA, 2012, 28 (03): : 211 - 213
  • [32] Rethymectomy in patients with non-thymomatous myasthenia gravis
    Kostera-Pruszczyk, A.
    Kaminska, A.
    Dutkiewicz, M.
    Pacho, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 262 - 262
  • [33] Comparative study for surgical management of thymectomy for non-thymomatous myasthenia gravis from the French national database EPITHOR
    Orsini, Bastien
    Santelmo, Nicola
    Pages, Pierre Benoit
    Baste, Jean Marc
    Dahan, Marcel
    Bernard, Alain
    Thomas, Pascal Alexandre
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 50 (03) : 418 - 422
  • [34] Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis
    Uzawa, Akiyuki
    Kawaguchi, Naoki
    Kanai, Tetsuya
    Himuro, Keiichi
    Oda, Fumiko
    Yoshida, Shigetoshi
    Yoshino, Ichiro
    Kuwabara, Satoshi
    JOURNAL OF NEUROLOGY, 2015, 262 (04) : 1019 - 1023
  • [35] Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis
    Kai Zhu
    Jiaoxing Li
    Xin Huang
    Wei Xu
    Weibin Liu
    Jiaxin Chen
    Pei Chen
    Huiyu Feng
    Neurological Sciences, 2017, 38 : 1753 - 1760
  • [36] Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis
    Akiyuki Uzawa
    Naoki Kawaguchi
    Tetsuya Kanai
    Keiichi Himuro
    Fumiko Oda
    Shigetoshi Yoshida
    Ichiro Yoshino
    Satoshi Kuwabara
    Journal of Neurology, 2015, 262 : 1019 - 1023
  • [37] Extended transcervical thymectomy with partial upper sternotomy: results in non-thymomatous patients with myasthenia gravis
    Ruffini, Enrico
    Guerrera, Francesco
    Filosso, Pier Luigi
    Bora, Giulia
    Nex, Giulia
    Gusmano, Simone
    Giobbe, Maria Laura
    Ciccone, Giovannino
    Bruna, Maria Cristina
    Giobbe, Roberto
    Solidoro, Paolo
    Lyberis, Paraskevas
    Oliaro, Alberto
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2015, 48 (03) : 448 - 454
  • [38] Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis
    Zhu, Kai
    Li, Jiaoxing
    Huang, Xin
    Xu, Wei
    Liu, Weibin
    Chen, Jiaxin
    Chen, Pei
    Feng, Huiyu
    NEUROLOGICAL SCIENCES, 2017, 38 (10) : 1753 - 1760
  • [39] Effects of thymectomy on late-onset non-thymomatous myasthenia gravis: systematic review and meta-analysis
    Jinwei Zhang
    Yuan Chen
    Hui Zhang
    Zhaoyu Yang
    Peng Zhang
    Orphanet Journal of Rare Diseases, 16
  • [40] Effects of thymectomy on late-onset non-thymomatous myasthenia gravis: systematic review and meta-analysis
    Zhang, Jinwei
    Chen, Yuan
    Zhang, Hui
    Yang, Zhaoyu
    Zhang, Peng
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)